Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Do Hedge Funds and Insiders Love Molson Coors Brewing Company (TAP)?

At the moment, there are many indicators shareholders can use to track publicly traded companies. Two of the most innovative are hedge fund and insider trading activity. At Insider Monkey, our research analyses have shown that, historically, those who follow the top picks of the best investment managers can beat the market by a significant margin (see just how much).

Equally as useful, bullish insider trading sentiment is another way to analyze the investments you’re interested in. As the old adage goes: there are a number of stimuli for a corporate insider to get rid of shares of his or her company, but just one, very simple reason why they would initiate a purchase. Various empirical studies have demonstrated the useful potential of this strategy if “monkeys” know where to look (learn more here).

Thus, it’s important to study the newest info for Molson Coors Brewing Company (NYSE:TAP).

Molson Coors Brewing Company (NYSE:TAP)

How are hedge funds trading Molson Coors Brewing Company (NYSE:TAP)?

In preparation for the third quarter, a total of 24 of the hedge funds we track were bullish in this stock, a change of 26% from the first quarter. With hedge funds’ capital changing hands, there exists a select group of key hedge fund managers who were boosting their holdings meaningfully.

According to our 13F database, Levin Capital Strategies, managed by John A. Levin, holds the biggest position in Molson Coors Brewing Company (NYSE:TAP). Levin Capital Strategies has a $163.5 million position in the stock, comprising 2.9% of its 13F portfolio. The second largest stake is held by Richard S. Pzena of Pzena Investment Management, with a $92.8 million position; 0.6% of its 13F portfolio is allocated to the company. Other hedge funds that hold long positions include David Costen Haley’s HBK Investments, Jim Simons’s Renaissance Technologies and David Harding’s Winton Capital Management.

Now, specific money managers were leading the bulls’ herd. Levin Capital Strategies, managed by John A. Levin, initiated the largest position in Molson Coors Brewing Company (NYSE:TAP). Levin Capital Strategies had 163.5 million invested in the company at the end of the quarter. Richard S. Pzena’s Pzena Investment Management also initiated a $92.8 million position during the quarter. The following funds were also among the new TAP investors: David Costen Haley’s HBK Investments, Jim Simons’s Renaissance Technologies, and David Harding’s Winton Capital Management.

How are insiders trading Molson Coors Brewing Company (NYSE:TAP)?

Insider buying is at its handiest when the primary stock in question has experienced transactions within the past half-year. Over the latest 180-day time frame, Molson Coors Brewing Company (NYSE:TAP) has experienced zero unique insiders purchasing, and zero insider sales (see the details of insider trades here).

Discover how hedge fund piggybacking can benefit you

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.